Cabiralizumab in Combination With Nivolumab and Neoadjuvant Chemotherapy in Patients With Localized Triple-negative Breast Cancer

Condition:   Triple Negative Breast Cancer Interventions:   Drug: Paclitaxel;   Drug: Carboplatin;   Biological: Nivolumab;   Biological: Cabiralizumab;   Procedure: Tumor biopsy;   Procedure: Bone marrow;   Procedure: Blood draw Sponsors:   Washington University School of Medicine;   Bristol-Myers Squibb Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials